Aukera Therapeutics
Basel
About Aukera Therapeutics
Aukera Therapeutics is a biotech company that develops novel therapeutics for patients suffering from mTOR protein-related diseases such as cancer and neurogenerative diseases. Aukera Therapeutics is a spin-off from the Biozentrum of the University of Basel.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $6.4M
- Funding stage: Seed
- Last round: Seed (Dec 2025)
- Website: aukera-tx.com
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/aukera-therapeutics-24648 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.